Grifols S.A
USUSDGrifols S.A (US:GIFLF) — Drug Manufacturers - General. Numărul de burse pe care se tranzacționează acțiunile companiei: 4. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.
- Grifols SA — GRF-P · MC ES Număr de înregistrare necunoscut
Despre companie
- Site web
- grifols.com
- Relații cu investitorii
- grifols.com/en/investors
- Sector
- Healthcare · Drug Manufacturers - General
- Sediu central
- NEW YORK, Spain
- Director general
- Jose Ignacio Abia Buenache
- Angajați
- 25 258
- Fondată
- 1909
- Acțiuni în circulație
- 422.36 mil.
- Free float
- 418.2 mil.
- Capitalizare de piață
- 7.57 mld. USD
- Insideri
- 31.19%
- Investitori instituționali
- 37.75%
- Industrie (SIC)
- Pharmaceutical Preparations
- Formă juridică
- 5RDO
- ISIN
- ES0171996012
- LEI
- 959800HSSNXWRKBK4N60
- Rata de distribuire
- 0%
- FCF
- 641 mil. EUR
- Datorie
- 8.52 mld. EUR11 ani FCF
- Vechimea dividendelor
- 1 ani
- Câștiguri, FCF și dividende plătite — pentru cele 12 luni până la 30.06.2026 (cel mai recent raport al companiei).
Descriere
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Dividende
Grifols S.A (GIFLF) plătește dividende o dată pe an. În ultimele 12 luni, s-au plătit 0.0824 EUR pe acțiune (plăți: 1).
| Data ex | Plată | Sumă | % | Tip | Simbol |
|---|---|---|---|---|---|
| 2026-07-01 | 2026-07-02 | 0.0824 EUR | 0.8/2.3 % | special | US:GIFLF |
| 2025-08-12 | 2025-08-13 | 0.1500 EUR | 1.5/1.5 % | special | US:GIFLF |
Știri din această săptămână
Încă nu există știri de pe site-ul companiei.
Cei mai mari acționari
| Deținător | Participație | Acțiuni | Data raportului |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1% | 4.28 mil. | 2026-04-30 |
| VANGUARD TAX-MANAGED FUN… | 0.66% | 2.8 mil. | 2026-06-30 |
| iShares Trust-iShares Co… | 0.49% | 2.08 mil. | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.34% | 1.46 mil. | 2026-04-30 |
| Dimensional ETF Trust-Di… | 0.25% | 1.07 mil. | 2026-04-30 |
| iShares Trust-iShares MS… | 0.22% | 935 128 | 2026-07-31 |
| DFA INVESTMENT TRUST CO-… | 0.17% | 741 772 | 2026-04-30 |
| VANGUARD Intl Eqy. INDEX… | 0.16% | 696 510 | 2026-04-30 |
| SCHWAB STRATEGIC TRUST-S… | 0.16% | 676 482 | 2026-05-31 |
| VANGUARD Intl Eqy. INDEX… | 0.15% | 634 298 | 2026-04-30 |
| Pacer Advisors, Inc. | 0% | 1 323 | 2026-06-30 |
